International Conference on
Clinical Surgery & Transplantation

Mr. De la Parra-Solomon is an entrepreneur focused on Information Technology, Education and Health. He is creative, results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra-Solomon is the Chief Strategy Officer and Co-Founder of the Quantum Brain Research Institute (www.quantumbrain.institute), a HealthTech initiative established in Tallinn, Estonia focused on Mental Health and Information Technology solutions.

Quantum Brain Research Institute

Ms. Susanna Uusmaa is a biomedical scientist with broad expertise in Medical Sciences and in International Business. Holding an MSBS degree, she is result-driven to integrate modern smart technologies into making substantive contributions to the biomedical sector. Having conducted research in neuroscience and oncology and having proudly graduated from Tallinn University of Technology (TALTECH) and Tallinn University School of Natural Sciences and Health, Ms. Uusmaa takes an evidence-based approach to her professional objectives and also to her endeavors as a passionate healthy lifestyle entrepreneuse.

Neuroscience, Biomedical Sciences, Neurology, Psychology, Psychiatry, Digital Health, Gene Technology, Biotechnology, Biology, Medicine, Genetics, Genomics, Mobile Health, Telemedicine, Information Technology

Josep M. Campistol is currently the General Director of the Hospital Clinic of Barcelona, Spain, and former Medical Director of the same hospital as well as Director of the Clinical Institute of Nephrology and Urology (ICNU). He is also Professor of Medicine at the Nephrology Department of the University of Barcelona. He received his medical degree from the University of Barcelona in 1983, and completed his residency in internal medicine and, subsequently, his fellowship in renal medicine at the Hospital Clinic of the same institution. Following his training as a fellow in renal medicine at the University of Barcelona, Prof. Campistol continued his clinical work in renal transplantation within the Renal Transplant Unit at the Hospital Clinic. During this period, he also developed research interests into the pathogenesis of dialysis-related amyloidosis, and undertook a visiting Fulbright Scholarship at Boston University School of Medicine in Boston, MA, USA (1991 to 1992). His doctoral thesis (1990) was based on the Pathogenesis of dialysis amyloidosis and the role of lymphocytes on beta 2 microglobulin synthesis and dialysis membranes. Prof. Campistol has published more than 700 experimental and clinical papers in international peer reviewed journals. He is a member of many international transplant societies, on the editorial board of a number of major international transplant journals and a principal investigator in numerous clinical studies. His current research interests include the use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

The use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

Mr.Nadir Ali is the Medical Director of “Esthetik”. He began his surgical career in 1995 and has worked in the field of cosmetic surgery since 2000. He has worked in both the private sector and the NHS as a Consultant Plastic, Reconstructive & Cosmetic Surgeon and is on the specialist register of the General Medical Council. He holds the specialist FRCS (Plast) qualification and has done Fellowships in Microsurgery , Rhinoplasty and Breast reconstruction. He has a wealth of private and NHS experience in carrying out the full range of surgical and non-surgical cosmetic procedures, including breast reduction; breast augmentation; mastopexy; otoplasty; gynaecomastia correction; facelifts; rhinoplasty, brow lifts; blephroplasty; labiaplasty; fillers; botox; chemical peels and liposuction. He has published many papers in peer reviewed journals and has presented papers at national and international conferences. He is a member of the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), the British Society for Surgery of the Hand (BSSH), the American society of Plastic surgeons (ASPS), The Royal College of Physicians and Surgeons of Glasgow (RCPSG) He has full practicing privileges for Euxton hall hospital, Oaklands hospital, Bearwood hospital and Fylde coast hospital.

surgical and non-surgical cosmetic procedures, including: breast reduction; breast augmentation; mastopexy; otoplasty; gynaecomastia correction; facelifts; rhinoplasty, brow lifts; blepharoplasty; labiaplasty; fillers; botox; chemical peels and liposuction.

Board Certified in Plastic Surgery since 1999. Member of the American Society of Aesthetic Surgery and the American Society of Plastic Surgeons. Dr. Gregory Turowski is one of a few double board-certified plastic surgeons specializing in plastic and cosmetic face and body surgery. He combines a European background with knowledge and technical expertise that he acquired through years of surgical training at the most prestigious American Ivy League institutions: Yale and Harvard.

reconstructive breast surgery for congenital breast anomalies, post-mastectomy breast cancer reconstruction, and breast reduction surgery

Dr. Askanase has her expertise evaluation in Associate Professor of Medicine – Clinical Director Lupus Center. In 1993-1994 Askanase worked as an Assistant Professor, Department of Internal Medicine, University of Medicine and Pharmacy, Carol Davila, Bucharest, Romania. From 2014 to present she working as an Associate Professor of Medicine, Columbia University Medical Center, New York. She is a member of Arthritis Foundation in 2005, Lupus Foundation of America in 2011. She awarded Rheumatology Outstanding Teacher Award – NYU School of Medicine in 2013, Clinical Director Columbia Lupus Center and Rheumatology Clinical Trials-CUMC, New York in 2014.

Rheumatology, Internal Medicine, Connective Tissue Diseases.

Seunghee Cha, DDS, PhD, has her expertise in the pathogenesis of Sjögren’s syndrome (SjS), focusing on the understanding of the altered salivary microenvironment and glandular regeneration. As a clinician/scientist, her long-term research goal has been to develop interventional strategies for patients suffering from SjS. This motivation allowed her to generate a SjS-prone mouse model, characterize altered SjS target tissue homeostasis, create a conjugate that protects salivary acinar cells in the SjS glandular microenvironment, profile SjS-associated miRNAs, and identify their putative target molecules. Additionally, Dr. Cha has identified via proteomics transcription factors that contribute to transdifferentiation of mesenchymal stem cells into salivary progenitor cells. Her lab is in the process of characterizing those transcription factors to identify the master regulators for the generation of saliva secreting cells. Her study summarized above was conducted to identify ways to bypass the need for a lip biopsy and improve the currently dubious diagnostic criteria for SjS.

Sjӧgren’s syndrome, Autoimmunity/autoantibodies, Salivary gland regeneration/Stem cells and miRNA in innate immunity.

I was graduated as medical doctor at Miguel Hernandez University in Elche (Spain), and subsequently, I developed my career in dermatology in Malaga (Spain). I started my experience in aesthetics (my great passion) in Grupo Pedro Jaen Clinic in 2006. Nowadays, I am head of dermatology area at Sanchinarro University HM Hospital and medical director at Dorsia clinics.

Cosmetic Surgery

Professor John Horowitz trained in Medicine in Adelaide, with subsequent clinical and research training in Cardiology and Clinical Pharmacology at the University of Melbourne. From 1980 to 1982 he was a postdoctoral research fellow at the Brigham and Women’s Hospital, Harvard University, Boston. In 1988 he was appointed as Director of Cardiology at the Queen Elizabeth Hospital, Adelaide, and Professor of Cardiology, Adelaide University. His major research interests centre on the pathogenesis and potential treatment of various forms of cardiovascular disease, including myocardial ischaemia, heart failure, atrial fibrillation, aortic valve stenosis and takotsubo syndrome. Among his specific pharmacological/therapeutic interests are the potential utilities of the cardiac metabolic manipulator perhexiline and the antioxidant N-acetylcysteine.

cardiology and clinical Pharmacology